stockrow
Friday 6 November 2026
Export BFLY’s income statement to Excel — free account
Butterfly Network, Inc.
BFLY Healthcare Medical Devices
Butterfly Network, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $97.6 million, up 19.0% from fiscal 2024.
- Revenue
- +51.7%
- EPS
- +63.0%
- Free cash flow
- +12.6%
Quarter to September 2026, against a year earlier
6.35
0.28
+4.61%
Follow BFLY
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | 3 | 3 |
+8 more TTM periods Free account |
| (27.65%) | (35.46%) | (35.17%) | (42.25%) | ||
| (18.58%) | (25.11%) | (25.08%) | (27.89%) | ||
ROIC |
(58.16%) | (76.64%) | (96.00%) | (118.73%) | |
Return on Tangible Assets |
(28.03%) | (38.35%) | (38.60%) | (38.42%) | |
Average Days of Receivables |
110.69 | 112.46 | 89.41 | 100.01 | |
Free Cash Flow per Share |
(0.10) | (0.11) | (0.07) | (0.06) | |
Free Cash Flow |
(27.55) | (28.04) | (18.86) | (16.05) | |
Capital Expenditures |
(4.15) | (4.02) | (3.94) | (3.35) | |
| Other line items | |||||
Cash ROIC |
(8.98%) | (8.93%) | (5.73%) | (4.63%) | |
Accounts Receivable Turnover |
3.99 | 3.80 | 4.56 | 4.11 | |
Accounts Payable Turnover |
8.18 | 15.53 | 20.52 | 10.70 | |
Inventory Turnover |
0.60 | 0.83 | 0.81 | 0.78 | |
Average Days of Payables |
56.33 | 24.18 | 19.67 | 38.29 | |
Days of Inventory on Hand |
593.27 | 402.46 | 414.07 | 431.93 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
32.11% | 33.98% | 34.86% | 37.15% | |
Selling, General and Administrative Expense of Revenue |
74.24% | 78.70% | 83.69% | 87.19% | |
Share Based Compensation of Revenue |
20.83% | 21.28% | 22.05% | 24.01% | |
Interest Coverage |
(46.83) | (59.42) | (57.54) | (58.00) | |
Operating CF/Net income |
0.44 | 0.32 | 0.20 | 0.16 | |
Depreciation/Fixed assets |
0.43 | 0.45 | 0.47 | 0.49 | |
Capex/Depreciation |
(0.61) | (0.57) | (0.52) | (0.41) | |
Revenue per Share |
0.46 | 0.43 | 0.40 | 0.40 | |
Operating CF per Share |
(0.09) | (0.09) | (0.06) | (0.05) | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.01) | |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.03 |
Columns are period end dates · fundamentals updated 6 Nov 2026